Balchem Net Income
| BCPC Stock | USD 180.81 3.32 1.87% |
As of the 15th of February 2026, Balchem shows the Mean Deviation of 1.08, risk adjusted performance of 0.1481, and Downside Deviation of 0.9491. Balchem technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Balchem Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 5.883 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 147.7 M | 155.1 M | |
| Net Income Applicable To Common Shares | 121.2 M | 127.2 M | |
| Net Income From Continuing Ops | 147.7 M | 83.6 M | |
| Net Income Per Share | 3.58 | 3.76 | |
| Net Income Per E B T | 0.69 | 0.55 |
Balchem | Net Income | Build AI portfolio with Balchem Stock |
Analyzing Balchem's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Balchem's current valuation and future prospects.
Latest Balchem's Net Income Growth Pattern
Below is the plot of the Net Income of Balchem over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Balchem financial statement analysis. It represents the amount of money remaining after all of Balchem operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Balchem's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Balchem's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 128.47 M | 10 Years Trend |
|
Net Income |
| Timeline |
Balchem Net Income Regression Statistics
| Arithmetic Mean | 80,404,165 | |
| Geometric Mean | 57,235,378 | |
| Coefficient Of Variation | 51.11 | |
| Mean Deviation | 32,097,587 | |
| Median | 79,671,000 | |
| Standard Deviation | 41,095,174 | |
| Sample Variance | 1688.8T | |
| Range | 154.7M | |
| R-Value | 0.97 | |
| Mean Square Error | 111.3T | |
| R-Squared | 0.94 | |
| Slope | 7,882,633 | |
| Total Sum of Squares | 27021T |
Balchem Net Income History
Other Fundumenentals of Balchem
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Balchem Net Income component correlations
Balchem Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Balchem is extremely important. It helps to project a fair market value of Balchem Stock properly, considering its historical fundamentals such as Net Income. Since Balchem's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Balchem's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Balchem's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Specialty Chemicals sector continue expanding? Could Balchem diversify its offerings? Factors like these will boost the valuation of Balchem. Projected growth potential of Balchem fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Balchem data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.204 | Dividend Share 0.87 | Earnings Share 4.57 | Revenue Per Share | Quarterly Revenue Growth 0.115 |
The market value of Balchem is measured differently than its book value, which is the value of Balchem that is recorded on the company's balance sheet. Investors also form their own opinion of Balchem's value that differs from its market value or its book value, called intrinsic value, which is Balchem's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Balchem's market value can be influenced by many factors that don't directly affect Balchem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Balchem's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Balchem should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Balchem's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Balchem 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Balchem's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Balchem.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Balchem on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Balchem or generate 0.0% return on investment in Balchem over 90 days. Balchem is related to or competes with Sensient Technologies, Sasol, Axalta Coating, Element Solutions, SSR Mining, Hawkins, and Perimeter Solutions. Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutrition... More
Balchem Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Balchem's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Balchem upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 0.9491 | |||
| Information Ratio | 0.1285 | |||
| Maximum Drawdown | 7.13 | |||
| Value At Risk | (1.53) | |||
| Potential Upside | 3.26 |
Balchem Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Balchem's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Balchem's standard deviation. In reality, there are many statistical measures that can use Balchem historical prices to predict the future Balchem's volatility.| Risk Adjusted Performance | 0.1481 | |||
| Jensen Alpha | 0.1929 | |||
| Total Risk Alpha | 0.1361 | |||
| Sortino Ratio | 0.1901 | |||
| Treynor Ratio | 0.3034 |
Balchem February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1481 | |||
| Market Risk Adjusted Performance | 0.3134 | |||
| Mean Deviation | 1.08 | |||
| Semi Deviation | 0.7592 | |||
| Downside Deviation | 0.9491 | |||
| Coefficient Of Variation | 560.79 | |||
| Standard Deviation | 1.4 | |||
| Variance | 1.97 | |||
| Information Ratio | 0.1285 | |||
| Jensen Alpha | 0.1929 | |||
| Total Risk Alpha | 0.1361 | |||
| Sortino Ratio | 0.1901 | |||
| Treynor Ratio | 0.3034 | |||
| Maximum Drawdown | 7.13 | |||
| Value At Risk | (1.53) | |||
| Potential Upside | 3.26 | |||
| Downside Variance | 0.9007 | |||
| Semi Variance | 0.5764 | |||
| Expected Short fall | (1.51) | |||
| Skewness | 0.7747 | |||
| Kurtosis | 0.8053 |
Balchem Backtested Returns
Balchem appears to be very steady, given 3 months investment horizon. Balchem secures Sharpe Ratio (or Efficiency) of 0.18, which signifies that the company had a 0.18 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Balchem, which you can use to evaluate the volatility of the firm. Please makes use of Balchem's Mean Deviation of 1.08, downside deviation of 0.9491, and Risk Adjusted Performance of 0.1481 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Balchem holds a performance score of 14. The firm shows a Beta (market volatility) of 0.79, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Balchem's returns are expected to increase less than the market. However, during the bear market, the loss of holding Balchem is expected to be smaller as well. Please check Balchem's jensen alpha, potential upside, accumulation distribution, as well as the relationship between the treynor ratio and expected short fall , to make a quick decision on whether Balchem's price patterns will revert.
Auto-correlation | 0.32 |
Below average predictability
Balchem has below average predictability. Overlapping area represents the amount of predictability between Balchem time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Balchem price movement. The serial correlation of 0.32 indicates that nearly 32.0% of current Balchem price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.32 | |
| Spearman Rank Test | 0.54 | |
| Residual Average | 0.0 | |
| Price Variance | 56.04 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Balchem Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Balchem reported net income of 128.47 M. This is 1167.56% lower than that of the Chemicals sector and 69.6% lower than that of the Materials industry. The net income for all United States stocks is 77.5% higher than that of the company.
Balchem Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Balchem's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Balchem could also be used in its relative valuation, which is a method of valuing Balchem by comparing valuation metrics of similar companies.Balchem is currently under evaluation in net income category among its peers.
Balchem ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Balchem's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Balchem's managers, analysts, and investors.Environmental | Governance | Social |
Balchem Institutional Holders
Institutional Holdings refers to the ownership stake in Balchem that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Balchem's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Balchem's value.| Shares | Jpmorgan Chase & Co | 2025-06-30 | 451.7 K | Schroder Investment Management Group | 2025-06-30 | 407.5 K | Northern Trust Corp | 2025-06-30 | 395.5 K | Charles Schwab Investment Management Inc | 2025-06-30 | 368.5 K | Congress Asset Management Company, Llp | 2025-06-30 | 362.1 K | Grantham, Mayo, Van Otterloo & Co., Llc | 2025-06-30 | 352.5 K | Nuveen, Llc | 2025-06-30 | 345.5 K | Clearbridge Advisors, Llc | 2025-06-30 | 335.8 K | Stephens Inv Mgmt Group Llc | 2025-06-30 | 275.4 K | Blackrock Inc | 2025-06-30 | 4.9 M | Vanguard Group Inc | 2025-06-30 | 3.9 M |
Balchem Fundamentals
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.0787 | ||||
| Profit Margin | 0.15 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 5.96 B | ||||
| Shares Outstanding | 32.39 M | ||||
| Shares Owned By Insiders | 0.30 % | ||||
| Shares Owned By Institutions | 91.88 % | ||||
| Number Of Shares Shorted | 294.2 K | ||||
| Price To Earning | 42.37 X | ||||
| Price To Book | 4.51 X | ||||
| Price To Sales | 5.79 X | ||||
| Revenue | 953.68 M | ||||
| Gross Profit | 363.07 M | ||||
| EBITDA | 230.95 M | ||||
| Net Income | 128.47 M | ||||
| Cash And Equivalents | 58.1 M | ||||
| Cash Per Share | 1.81 X | ||||
| Total Debt | 208.04 M | ||||
| Debt To Equity | 0.53 % | ||||
| Current Ratio | 2.59 X | ||||
| Book Value Per Share | 40.09 X | ||||
| Cash Flow From Operations | 182 M | ||||
| Short Ratio | 1.92 X | ||||
| Earnings Per Share | 4.57 X | ||||
| Price To Earnings To Growth | 4.84 X | ||||
| Target Price | 191.0 | ||||
| Number Of Employees | 1.35 K | ||||
| Beta | 0.95 | ||||
| Market Capitalization | 5.87 B | ||||
| Total Asset | 1.58 B | ||||
| Retained Earnings | 997.49 M | ||||
| Working Capital | 156.09 M | ||||
| Current Asset | 198.83 M | ||||
| Current Liabilities | 81.12 M | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 0.48 % | ||||
| Net Asset | 1.58 B | ||||
| Last Dividend Paid | 0.87 |
About Balchem Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Balchem's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Balchem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Balchem based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Balchem offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Balchem's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Balchem Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Balchem Stock:Check out For information on how to trade Balchem Stock refer to our How to Trade Balchem Stock guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Will Specialty Chemicals sector continue expanding? Could Balchem diversify its offerings? Factors like these will boost the valuation of Balchem. Projected growth potential of Balchem fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Balchem data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.204 | Dividend Share 0.87 | Earnings Share 4.57 | Revenue Per Share | Quarterly Revenue Growth 0.115 |
The market value of Balchem is measured differently than its book value, which is the value of Balchem that is recorded on the company's balance sheet. Investors also form their own opinion of Balchem's value that differs from its market value or its book value, called intrinsic value, which is Balchem's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Balchem's market value can be influenced by many factors that don't directly affect Balchem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Balchem's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Balchem should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Balchem's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.